BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

317 related articles for article (PubMed ID: 28364212)

  • 21. Anatomical versus nonanatomical resection of colorectal liver metastases: is there a difference in surgical and oncological outcome?
    Lalmahomed ZS; Ayez N; van der Pool AE; Verheij J; IJzermans JN; Verhoef C
    World J Surg; 2011 Mar; 35(3):656-61. PubMed ID: 21161655
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Techniques of parenchyma-sparing hepatectomy for the treatment of tumors involving the hepatocaval confluence: A reliable way to assure an adequate future liver remnant volume.
    Urbani L; Colombatto P; Balestri R; Licitra G; Leoni C; Forfori F; Masi G; Boraschi P; Castagna M; Buccianti P
    Surgery; 2017 Sep; 162(3):483-499. PubMed ID: 28549521
    [TBL] [Abstract][Full Text] [Related]  

  • 23. R1 Resection for Colorectal Liver Metastases: a Survey Questioning Surgeons about Its Incidence, Clinical Impact, and Management.
    Viganò L; Costa G; Cimino MM; Procopio F; Donadon M; Del Fabbro D; Belghiti J; Kokudo N; Makuuchi M; Vauthey JN; Torzilli G
    J Gastrointest Surg; 2018 Oct; 22(10):1752-1763. PubMed ID: 29948554
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical outcomes of parenchymal-sparing versus anatomic resection for colorectal liver metastases: a systematic review and meta-analysis.
    Wang K; Liu Y; Hao M; Li H; Liang X; Yuan D; Ding L
    World J Surg Oncol; 2023 Aug; 21(1):241. PubMed ID: 37553574
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long-term oncologic results of anatomic vs. parenchyma-sparing resection for hepatocellular carcinoma. A propensity score-matching analysis.
    Famularo S; Di Sandro S; Giani A; Lauterio A; Sandini M; De Carlis R; Buscemi V; Romano F; Gianotti L; De Carlis L
    Eur J Surg Oncol; 2018 Oct; 44(10):1580-1587. PubMed ID: 29861336
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Laparoscopic Multiple Parenchyma-sparing Concomitant Liver Resections for Colorectal Liver Metastases.
    Kazaryan AM; Aghayan DL; Barkhatov LI; Fretland ÅA; Edwin B
    Surg Laparosc Endosc Percutan Tech; 2019 Jun; 29(3):187-193. PubMed ID: 30520815
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Laparoscopic parenchymal preserving liver resections for colorectal liver metastases in the era of highly effective systemic therapy and selective internal radiation therapy can often prevent a hemihepatectomy. (With video).
    D'Hondt M; Ververken F; Nuytens F
    Surg Oncol; 2017 Dec; 26(4):345-346. PubMed ID: 29113650
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Upper transversal hepatectomy with double hepatic vein resection and reconstruction to treat colorectal cancer liver metastases at the hepatocaval confluence: a strategy to achieve R0 liver-sparing resection.
    Urbani L; Roffi N; Signori S; Balestri R; Colombatto P; Licitra G; Leoni C; Meiattini D; Moretto R; Cremolini C; Masi G; Boraschi P; Quilici F; Buccianti P; Puccini M
    Langenbecks Arch Surg; 2022 Jun; 407(4):1741-1750. PubMed ID: 35028737
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impact of type of liver resection on the outcome of colorectal liver metastases: a case-matched analysis.
    Guzzetti E; Pulitanò C; Catena M; Arru M; Ratti F; Finazzi R; Aldrighetti L; Ferla G
    J Surg Oncol; 2008 May; 97(6):503-7. PubMed ID: 18425789
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Modern trends in minimally invasive versus open hepatectomy for colorectal liver metastasis: an analysis of ACS-NSQIP.
    Carpenter EL; Thomas KK; Adams AM; Valdera FA; Chick RC; Kemp Bohan PM; Spitzer HV; Clifton GT; Bader JO; Nelson DW; Vreeland TJ
    Surg Endosc; 2023 Jul; 37(7):5591-5602. PubMed ID: 36344895
    [TBL] [Abstract][Full Text] [Related]  

  • 31. R1 resection by necessity for colorectal liver metastases: is it still a contraindication to surgery?
    de Haas RJ; Wicherts DA; Flores E; Azoulay D; Castaing D; Adam R
    Ann Surg; 2008 Oct; 248(4):626-37. PubMed ID: 18936576
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Increased use of parenchymal-sparing surgery for bilateral liver metastases from colorectal cancer is associated with improved mortality without change in oncologic outcome: trends in treatment over time in 440 patients.
    Gold JS; Are C; Kornprat P; Jarnagin WR; Gönen M; Fong Y; DeMatteo RP; Blumgart LH; D'Angelica M
    Ann Surg; 2008 Jan; 247(1):109-17. PubMed ID: 18156930
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Combined ablation and resection (CARe) as an effective parenchymal sparing treatment for extensive colorectal liver metastases.
    Evrard S; Poston G; Kissmeyer-Nielsen P; Diallo A; Desolneux G; Brouste V; Lalet C; Mortensen F; Stättner S; Fenwick S; Malik H; Konstantinidis I; DeMatteo R; D'Angelica M; Allen P; Jarnagin W; Mathoulin-Pelissier S; Fong Y
    PLoS One; 2014; 9(12):e114404. PubMed ID: 25485541
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Outcomes of different parenchymal-sparing hepatectomies in patients with colorectal liver metastases and prognostic impact of peritumoral imaging features.
    Liu L; Xie L; Zhou Y; Li Q; Lei X; Tang H; Wu J; Zhao X; Yang P; Mao Y
    Abdom Radiol (NY); 2023 Dec; 48(12):3728-3745. PubMed ID: 37750923
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Twelve-year experience of "radical but conservative" liver surgery for colorectal metastases: impact on surgical practice and oncologic efficacy.
    Torzilli G; Viganò L; Gatti A; Costa G; Cimino M; Procopio F; Donadon M; Del Fabbro D
    HPB (Oxford); 2017 Sep; 19(9):775-784. PubMed ID: 28625391
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Is Tumor Detachment from Vascular Structures Equivalent to R0 Resection in Surgery for Colorectal Liver Metastases? An Observational Cohort.
    Viganò L; Procopio F; Cimino MM; Donadon M; Gatti A; Costa G; Del Fabbro D; Torzilli G
    Ann Surg Oncol; 2016 Apr; 23(4):1352-60. PubMed ID: 26714946
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Anatomical Resections Improve Disease-free Survival in Patients With KRAS-mutated Colorectal Liver Metastases.
    Margonis GA; Buettner S; Andreatos N; Sasaki K; Ijzermans JNM; van Vugt JLA; Pawlik TM; Choti MA; Cameron JL; He J; Wolfgang CL; Weiss MJ
    Ann Surg; 2017 Oct; 266(4):641-649. PubMed ID: 28657938
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Innovation and Future Perspectives in the Treatment of Colorectal Liver Metastases.
    Vauthey JN; Kawaguchi Y
    J Gastrointest Surg; 2020 Feb; 24(2):492-496. PubMed ID: 31797258
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Parenchymal sparing surgery brings treatment of colorectal liver metastases into the precision medicine era.
    Evrard S; Torzilli G; Caballero C; Bonhomme B
    Eur J Cancer; 2018 Nov; 104():195-200. PubMed ID: 30380461
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Practical Contribution of Virtual Hepatectomy for Colorectal Liver Metastases: a Propensity-Matched Analysis of Clinical Outcome.
    Takamoto T; Sano K; Hashimoto T; Ichida A; Shimada K; Maruyama Y; Makuuchi M
    J Gastrointest Surg; 2018 Dec; 22(12):2037-2044. PubMed ID: 29980979
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.